Algeria Pharmaceuticals Tenders and Bids

Get access to latest Algeria pharmaceutical tenders and bids. Find business opportunities and business intelligence for Algeria pharmaceutical tenders, Algeria pharmaceuticals bids contracts, pharma public procurement notices, Algeria drugs tenders, Algeria medicine tenders, Algeria generic medicine tenders, pharmaceutical market reports, pharmaceutical market intelligence. Find Algeria tenders, bids, procurement, RFPs, RFQs, ICBs. Search for Algeria pharmaceutical tenders online. The country has enjoyed several years of strong economic performance, with solid non-hydrocarbon growth, low inflation, an overall budget surplus of 8% of GDP and a positive trade balance of 28% of GDP in 2008. Average annual non-hydrocarbon GDP growth averaged 6 percent in 2003–2007, with total GDP growing at an average of 4.5% during the same period due to less buoyant oil production in 2006–07. After having virtually eliminated external debt before 2013, the drop hydrocarbon prices and revenues has led to a large budget deficit which has been only partly offset by spending cuts. Consequently, government debt has increased to more than 30% of GDP. Inflation has remained at 3-6% on average for 2013–17. However, the economy remains highly dependent on hydrocarbons, which represent 94% of total exports; a continued slowdown of global energy demand has significantly put pressure on Algeria's fiscal and external positions. The nominal GDP in 2017 was US$167.5 billion. Algeria has enormous possibilities to boost its economic growth, including huge foreign-exchange reserves derived from oil and gas. A development strategy targeting stronger, sustained growth would create more jobs, especially for young people, and alleviate the housing shortage the country is facing. The national strategic option is therefore to revitalise the process intended to diversify the economy starting with the non-oil sector while deepening the reforms needed for the structural transformation of the economy. The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%.